S0354 anti-IL-6 chimeric monoclonal antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for S0354 anti-IL-6 chimeric monoclonal antibody, covering 2013-02-05 to 2013-02-05. Get the full timeline:
Most recent: Clinical Trial Update: S0354, Anti-IL-6 Chimeric Monoclonal Antibody in Patients With Metastatic Prostate Cancer That Did Not Respond to Hormone Therapy [Phase 2]